Exai stock forecast.
Company’s recent per share price level of $6.10 trading at $0.13 or 2.18% at ring of the bell on the day assigns it a market valuation of $762.13M. That closing price of EXAI’s stock is at a discount of -88.85% from its 52-week high price of $11.52 and is indicating a premium of 32.95% from its 52-week low price of $4.09.
Stock analysis for Exscientia Plc (EXAI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Find the latest Hon Hai Precision Industry Co., Ltd. (HNHPF) stock quote, history, news and other vital information to help you with your stock trading and investing.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Get the latest Exscientia PLC (EXAI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
The 4 analysts offering 1 year price forecasts for EXAI have a max estimate of — and a min estimate of —. Analyst rating Based on 4 analysts giving stock ratings to EXAI in the past 3 months.Nov 15, 2023 · Exscientia PLC Sponsored ADR (EXAI) closed the last trading session at $5.82, gaining 9.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ... Get Our Latest Stock Analysis on EXAI. Exscientia Stock Performance. Shares of NASDAQ EXAI opened at $6.17 on Monday. The business’s 50-day simple moving average is $5.38 and its 200-day simple ...
Dec 1, 2023 · 2012. 481. Andrew Hopkins. https://www.exscientia.ai. Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and ... Exscientia's AI-driven drug discovery platform positioned the company at the forefront of precision medicine. Read why EXAI stock is a Buy.
EPS Estimate Trends. Current. N/A. 1 Month Ago. N/A. 3 Months Ago. N/A. Exscientia PLC ADR analyst estimates, including EXAI earnings per share estimates and analyst recommendations. EXAI is trading at a 57% discount. Price $6.05 Nov 29, 2023 Fair Value $76.21 Nov 29, 2023 Uncertainty Extreme 1-Star Price $42.68EXAI | A complete EXAI overview by MarketWatch. View the latest market news and prices, and trading information.THIS MORNING'S STOCK NEWS MOVERS: (source: cnbc.com) Walmart (WMT) – Walmart shares surged 6.9% in the premarket after the retailer reported better-than-expected quarterly profit and revenue, and also saw comparable store sales exceed estimates. Walmart also announced a $20 billion share repurchase program.EXAI's current price target is $10.25. Learn why top analysts are making this stock forecast for Exscientia at MarketBeat.
Complete Exscientia PLC ADR stock information by Barron's. View real-time EXAI stock price and news, along with industry-best analysis.
On average, Wall Street analysts predict that Exscientia 's share price could reach $10.00 by Oct 17, 2024. The average Exscientia stock price prediction forecasts a potential …
Earnings announcement* for EXAI: Nov 16, 2022. Exscientia Plc is estimated to report earnings on 11/16/2022. The upcoming earnings date is derived from an algorithm based on a company's historical ...EPS Estimate Trends. Current. N/A. 1 Month Ago. N/A. 3 Months Ago. N/A. Exscientia PLC ADR analyst estimates, including EXAI earnings per share estimates and analyst recommendations.Morphic Holding, Inc. (NASDAQ:MORF) released its quarterly earnings results on Thursday, November, 4th. The company reported ($0.69) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.73) by $0.04. The company had revenue of $3.10 million for the quarter, compared to the consensus estimate of …The consensus price target hints at a 76.1% upside potential for Exscientia PLC Sponsored ADR (EXAI). While empirical research shows that this sought-after metric is hardly effective, an upward ... Exscientia EXAI is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here's what investors need to know before the announcement. Analysts estimate that Exscientia will ...
Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...OXFORD, U.K., September 20, 2023--Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Merck KGaA, Darmstadt, Germany focused on the discovery of novel small molecule drug ...As of March 20, 2023, 4:00 PM CST, Exscientia PLC (ADR)’s stock price was $5.94. Exscientia PLC (ADR) is down 8.33% from its previous closing price of $6.48. During the last market session, Exscientia PLC (ADR)’s stock traded between $6.25 and $6.92. Currently, there are 122.67 million shares of Exscientia PLC (ADR) stock available for ...In the example shown above, the formula in cell D13 is: = FORECAST.ETS (B13, sales, periods,4) where sales (C5:C12) and periods (B5:B12) are named ranges. With these inputs, the FORECAST.ETS function returns 618.29 in cell D13. As the formula is copied down the table, FORECAST.ETS returns predicted values in D13:D16, using values in column B ...Based on the latest available data, EXAI has gained about 7.1% so far this year. Meanwhile, the Medical sector has returned an average of -7.7% on a year-to-date basis. This shows that Exscientia ...
Exscientia EXAI is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here's what investors need to know before the announcement. Analysts estimate that Exscientia will ...
EXAI vs. PRTC, DYN, AUTL, COGT, TARS, ETNB, CALT, WVE, ICVX, and ICPT. Should you be buying Exscientia stock or one of its competitors? The main competitors of Exscientia include PureTech Health (PRTC), Dyne Therapeutics (DYN), Autolus Therapeutics (AUTL), Cogent Biosciences (COGT), Tarsus Pharmaceuticals …Based on analysts offering 12 month price targets for EXAI in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Compiled here, all relevant comments and discussions regarding the EXAI stock. ... What is the three-year EBITDA forecast for Alibaba (BABA)?TipRanks | Stock Market Research, News and Analyst Forecasts ... Citigroup, 5. Procter & Gamble, 6. Walmart, 7. Bank of America, 8. Johnson & Johnson, 9. American International Group, and 10. Pfizer. Many of those stocks have gone sideways or dropped ...Dec 2, 2023 · The consensus price target of analysts on Wall Street is $9.50, which implies an increase of 35.05% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7.00 and $11.00 respectively. As a result, EXAI is trading at a discount of -78.28% off the target high and -13.45% off the low. Exscientia EXAI is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here's what investors need to know before the announcement. Analysts estimate that Exscientia will ...
The mean of analysts' price targets for Exscientia PLC Sponsored ADR (EXAI) points to a 68% upside in the stock. While this highly sought-after metric has not proven …
We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...
The Exscientia Ltd ADR stock forecast is 16.939064819009 USD for 2024 November 09, Saturday; and 73.971 USD for 2028 November 09, Thursday with technical analysis. Exscientia Ltd ADR (EXAI) stock price prediction is 16.939064819009 USD.See the latest Exscientia PLC ADR stock price (EXAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions.May 24, 2023 · What is Exscientia plc (EXAI) stock EPS forecast? Exscientia plc missed analysts’ expectations during the last earnings period by -188.37% . Exscientia plc reported earnings of -$ 0.38 per share on May 24, 2023, while the forecasted EPS was $ 0.43. Exscientia stock price predictions for 2024 using artificial intelligence. How much will Exscientia stock be worth in 2024? ... Detailed predictions for EXAI stock ...Dec 1, 2023 · Stock analysis for Exscientia Plc (EXAI:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Nov 29, 2023 · See the latest Exscientia PLC ADR stock price (EXAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Find out why EXAI stock is a Buy. Exscientia has partnered with Merck KGaA for AI-powered drug discovery in complex disease segments. Find out why EXAI stock is a Buy. ... Predictions, predictions ...The extremes of the forecast give a target low and a target high price of $2.00 and $8.00 respectively. As a result, PBYI is trading at a discount of -113.33% off the target high and 46.67% off the low. Puma Biotechnology Inc (PBYI) estimates and forecasts. Yet analysts are ramping up their growth forecast for the fiscal year 2023.AUTL. Autolus Therapeutics PLC. 4.80. UNCH. UNCH. Get Exscientia PLC (EXAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Nov 18, 2023 · Company’s recent per share price level of $6.10 trading at $0.13 or 2.18% at ring of the bell on the day assigns it a market valuation of $762.13M. That closing price of EXAI’s stock is at a discount of -88.85% from its 52-week high price of $11.52 and is indicating a premium of 32.95% from its 52-week low price of $4.09. Aug 1, 2023 · Summary. Exscientia, a pioneer in AI-driven drug development, is using artificial intelligence to accelerate the discovery and preclinical phases of drug development. The company's stock traded ... What this means: Exscientia Ltd ADR (EXAI) gets an Overall Rank of 56, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Like Recursion, Exscientia (NYSE: EXAI) uses AI in its approach to drug discovery.Unlike Recusion, Exscientia aims to develop bespoke drug solutions for patients. Exscientia was the first to bring ...Instagram:https://instagram. tbsixtoggle insurance reviewsduk stock dividendekopark As of March 20, 2023, 4:00 PM CST, Exscientia PLC (ADR)’s stock price was $5.94. Exscientia PLC (ADR) is down 8.33% from its previous closing price of $6.48. During the last market session, Exscientia PLC (ADR)’s stock traded between $6.25 and $6.92. Currently, there are 122.67 million shares of Exscientia PLC (ADR) stock available for ... trading fundingeasiest finance certifications Their UBER share price targets range from $41.00 to $72.00. On average, they anticipate the company's stock price to reach $56.72 in the next twelve months. This suggests that the stock has a possible downside of 1.7%. View analysts price targets for UBER or view top-rated stocks among Wall Street analysts.The forecasts range from a low of $7.00 to a high of $13.00. The average price target represents an increase of 100.98% from the last closing price of $5.10. Analyst Price Targets (4 ) autozone stocks 9 Wall Street analysts have issued 1 year price targets for Magellan Midstream Partners' stock. Their MMP share price targets range from $56.00 to $69.00. On average, they anticipate the company's share price to reach $62.00 in the next twelve months. This suggests that the stock has a possible downside of 10.1%.According to . 3 Wall Street analysts that have issued a 1 year EXAI price target, the average EXAI price target is $10.00, with the highest EXAI stock price forecast at $13.00 and the lowest EXAI stock price forecast at $7.00.